title: [Catheter treatment of hypertrophic obstructive cardiomyopathy].
abstract: OBJECTIVE
  In addition to medication with negative inotropic drugs, surgical myectomy and DDD pacemaker implantation are standard procedures in the treatment of hypertrophic obstructive cardiomyopathy (HOCM). In a preliminary series the results obtained with a recently described method, consisting of transcatheter myocardial reduction, are evaluated.
  
  
  METHODS
  Six patients (two women, four men; mean age 52.7 [44-68] years), who remained in moderate heart failure despite medical treatment, underwent the procedure. After atrial transseptal puncture (via a catheter introduced percutaneously into the femoral vein) the left ventricular outflow tract (LVOT) gradient was measured at rest and after 5-minute balloon occlusion of the first septal branch of the left coronary artery. After demonstration of significant reduction of the gradient by the occlusion, one (n = 3) or two (n = 3) septal branches were occluded by the injection of 2-5 ml of 96% alcohol.
  
  
  RESULTS
  The LVOT gradient was reduced from 57.8 +/- 22.4 (38-97) mm Hg to 11.3 +/- 8.6 (0-21) mm Hg and postextrasystolic from 131.0 +/- 40.7 (78-198) mm Hg to 44.0 +/- 35.6 (19-69) mm Hg. All patients had angina for 24 hours after the procedure. Maximal rise in creatine kinase activity was 982 +/- 589 (392-1729) U/l after 8.0 +/- 3.9 (4-15) hours. In three patients transitory complete atrioventricular block developed 10 min to 5 days later, requiring temporary pacemaker implantation. The further course was without complication in all patients and they were discharged after 7.5 +/- 1.8 (6-11) days.
  
  
  CONCLUSIONS
  The described catheter method provides a nonsurgical means of reducing the amount of septal myocardium with subsequent reduction of the LVOT gradient in HOCM. Long-term observation in a larger group of patients and comparison with conventional forms of treatment are required to determined the method's ultimate place in the treatment of HOCM.
authors.affiliation: Kardiologische Klinik, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen.
authors.forename: U
authors.initials: U
authors.lastname: Gleichmann
authors.forename: H
authors.initials: H
authors.lastname: Seggewiss
authors.forename: L
authors.initials: L
authors.lastname: Faber
authors.forename: D
authors.initials: D
authors.lastname: Fassbender
authors.forename: H K
authors.initials: HK
authors.lastname: Schmidt
authors.forename: S
authors.initials: S
authors.lastname: Strick
mesh_terms: D000328:Adult; D000368:Aged; D000792:Angiography; D006328:Cardiac Catheterization; D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy*; D004452:Echocardiography; D004562:Electrocardiography; D004621:Embolization, Therapeutic / Q000379:methods*; D005069:Evaluation Studies as Topic; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged
vernacular_title: Kathetertherapie der hypertrophen obstruktiven Kardiomyopathie.